跳至主要内容
临床试验/NL-OMON56473
NL-OMON56473招募中不适用

The EXPLAIN Study: Exploring plant-based meat analogues for their Impact on health - EXPLAI

Wageningen Universiteit0 个研究点目标入组 114 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
114

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - BMI of 23-40 kg/m2;
  • - Age 45-75 years;
  • - Willing to consume both meat and PBMAs;
  • - Stable body weight (lost/gained ±<3 kg over the last 3 months prior to
  • inclusion).

排除标准

  • - Diseases or prior surgeries affecting the stomach, liver, kidneys or
  • intestines (allowed i.e. appendectomy);
  • - Food allergies, intolerances (including lactose/gluten intolerance) for
  • products used in the study design and/or dietary restrictions interfering with
  • the study (including special diets, vegetarians and eating disorders);
  • - Cardiovascular diseases (e.g. heart failure. But hypertension up to 160 mmHg
  • is allowed for inclusion as indicated by the research physician) or cancer
  • (e.g. non-invasive skin cancer allowed);
  • - Anaemia defined as Hb concentrations <8.5 mmol/L for men and <7.5 mmol/L for
  • - Diagnosed with type 1 or type 2 diabetes;
  • - Blood pressure >160 mmHg*;
  • - Major mental disorders;
  • - Drug treated thyroid diseases (well substituted hypothyroidism is allowed for
  • inclusion);
  • - Diseases with a life expectation shorter than 5 years.
  • - Regular use of/receiving medication interfering with research outcomes (as
  • judged by research physician), such as use of glucose lowering drugs, insulin,
  • use of medication that impacts gastric emptying, use of antipsychotics;
  • - Starting or changing blood pressure medication type or dose during the study.
  • (Continuation of blood pressure medication usage is allowed during study);
  • - Use of anti-biotics over the last 3 months before study start.
  • - Dietary habits interfering with study design (vegan/vegetarian, ketogenic
  • diet etc.);
  • - Intention to change the intensity of exercise during the study period;
  • - Intention to lose weight during the study period;
  • - Current smokers (including use of e-cigarettes);
  • - Use of soft and/or hard drugs (cannabis included);
  • - Abuse of alcohol (alcohol consumption defined as >14 glasses (women) or >21
  • glasses (men) of alcoholic beverages per week);
  • - Use of strong vitamins or other dietary supplements (e.g. iron- or
  • B12-supplements, pre- or probiotics) expected to interfere with the study
  • - Donated blood within 2 months prior to the screening;
  • - Inability to comply with the study diet;
  • - Being pregnant or lactating or planning to become pregnant;
  • - Unable/unwilling to download a research application on the mobile phone;
  • - Inability to understand study information and/or communicate with staff;
  • - Inability/unwillingness to comply to staff instructions;
  • - Displaying misbehaviour towards other participants/staff;
  • - Participation in another study that involves an intervention within two
  • months prior to the intervention;
  • - Working or doing a thesis/internship at the division of Human Nutrition and
  • Health or the Laboratory of Microbiology of Wageningen University.
  • *Participants with a screening systolic blood pressure >145 mmHg - <=160 mmHg
  • need written permission for participation without having (medical) treatment
  • for the study period granted by their general practitioner after assessment of
  • their cardiovascular risk. Participants within this screening range that cannot
  • handover written clearance of their general practitioner will be excluded from
  • participation. Participants whose blood pressure has measured >140 mmHg
  • (systolic) or >90 mmHg (diastolic) one or more times during the study, will
  • receive a letter for referral to the general practitioner.

研究者

相似试验